<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2024-1S-12-18</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2373</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>Demographic and comorbid factors associated with the development of medication overuse headache</article-title><trans-title-group xml:lang="ru"><trans-title>Демографические и коморбидные факторы, ассоциированные с развитием лекарственно-индуцированной головной боли</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-6211-0428</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Князева</surname><given-names>Я. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kniazeva</surname><given-names>Ia. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яна Алексеевна Князева</p><p>620028, Екатеринбург, ул. Репина, 3</p><p>620144, Екатеринбург, ул. Фурманова,67</p></bio><bio xml:lang="en"><p>Iana Alekseevna Knyazeva</p><p>3, Repina St., Yekaterinburg 620028 </p><p>67, Furmanova St., Yekaterinburg 620144</p></bio><email xlink:type="simple">neuro_k@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1040-5696</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гилёв</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gilev</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>620062, Екатеринбург, ул. Мира, 19</p></bio><bio xml:lang="en"><p>19 Mira St., Yekaterinburg 620062</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1989-5460</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Osipova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115093, Москва, ул. Люсиновская, 39, стр. 2</p><p>115419, Москва, ул. Донская, 43</p></bio><bio xml:lang="en"><p>39, Lyusinovskaya St., Build. 2, Moscow, 115093</p><p>43, Donskaya St., Build. 5, Moscow 115419</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2463-7113</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедева</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedeva</surname><given-names>E. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>620028, Екатеринбург, ул. Репина, 3</p><p>620144, Екатеринбург, ул. Фурманова,67</p></bio><bio xml:lang="en"><p>3, Repina St., Yekaterinburg 620028 </p><p>67, Furmanova St., Yekaterinburg 620144</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кафедра госпитальной терапии ФГБОУ ВПО «Уральский государственный медицинский университет» Минздрава России ; ООО «Международный медицинский центр Европа–Азия»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Hospital Therapy, Ural State Medical University, Ministry of Health of Russia ; LLC “International Center “Europe–Asia”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Кафедра экономики Института экономики и управления ФГАОУ ВО «Уральский федеральный университет им. первого Президента России Б.Н. Ельцина»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Economics, Institute of Economics and Management, Ural Federal University named after the First President of Russia B.N. Yeltsin</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ООО «Университетская клиника» ; ГБУЗ «Научно-практический психоневрологический центр им. З.П. Соловьева Департамента здравоохранения города Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>LLC “University Clinic” ; Z.P. Solovyev Research and Practical Psychoneurology Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2024</year></pub-date><volume>16</volume><issue>1S</issue><issue-title>Спецвыпуск: Головная боль</issue-title><fpage>12</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kniazeva I.A., Gilev D.V., Osipova V.V., Lebedeva E.R., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Князева Я.А., Гилёв Д.В., Осипова В.В., Лебедева Е.Р.</copyright-holder><copyright-holder xml:lang="en">Kniazeva I.A., Gilev D.V., Osipova V.V., Lebedeva E.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2373">https://nnp.ima-press.net/nnp/article/view/2373</self-uri><abstract><sec><title>Objective</title><p>Objective: to conduct a comparative analysis of factors associated with the development of medication overuse headache (MOH), considering demographic characteristics of patients and comorbid pathology.</p></sec><sec><title>Material and methods</title><p>Material and methods. A prospective study was conducted at "Europe–Asia" International Medical Center. The main group comprised patients with primary headache (HA) aged 18 years and older with MOH, and the control group comprised patients with primary HA without MOH of comparable gender and age. A semi-structured interview was conducted with the patients and additional examinations were performed, including MRI of the brain if indicated. The study included 171 patients with MOH (mean age 43.3 years, 82% women) and 173 patients without MOH (mean age 41.4 years, 75% women).</p></sec><sec><title>Results</title><p>Results. Chronic migraine occurred more frequently in the MOH group (53 and 16%, respectively; p&lt;0.001; OR 5.9; 95% CI 3.6–9.8). One third of patients in both groups suffered from chronic tension-type headache (CTH). Episodic migraine and episodic CTH occurred more frequently in patients without MOH (p&lt;0.001). Patients in the MOH group were more frequently divorced (11.7 and 2.9%, respectively; p=0.002; OR 4.5; 95% CI 1.6–12.2). The majority of patients (76%) in both groups were employed, had a higher education (65% with MOH and 74% without MOH) and were married (63% with MOH and 72% without MOH).The analysis of more than 20 comorbid diseases revealed that three factors were most frequently associated with the development of MOH: chronic insomnia (60.2 and 47.4% respectively; p=0.02; OR 1.7; 95% CI 1.1–2.6), restless legs syndrome (37.4 and 22% respectively; p=0.002; OR 2.1; 95% CI 1.3–3.4) and subjective cognitive impairment (76 and 53.2% respectively; p&lt;0.001; OR 2.8; 95% CI 1.8–4.8).</p></sec><sec><title>Conclusion</title><p>Conclusion. Sleep disturbance, subjective cognitive impairment and marital status of patients are most frequently associated with MOH, indicating the great importance of these factors in the development of MOH and opening new opportunities for its prevention.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Цель исследования – провести сравнительный анализ факторов, ассоциированных с развитием лекарственно-индуцированной головной боли (ЛИГБ), с учетом демографических характеристик пациентов и коморбидной патологии.</p><sec><title>Материал и методы</title><p>Материал и методы. Проспективное исследование проведено на базе Международного медицинского центра «Европа–Азия». Основную группу составили пациенты с первичной головной болью (ГБ) в возрасте 18 лет и старше, имеющие ЛИГБ, контрольную группу – сопоставимые по полу и возрасту пациенты с первичной ГБ без ЛИГБ. С пациентами проведено полуструктурированное интервью, а также по показаниям дополнительные исследования, включая МРТ головного мозга. В исследование включен 171 пациент с ЛИГБ (средний возраст – 43,3 года, 82% – женщины) и 173 пациента без ЛИГБ (средний возраст – 41,4 года, 75% – женщины).</p></sec><sec><title>Результаты</title><p>Результаты. Хроническая мигрень превалировала в группе ЛИГБ (53 и 16% соответственно; р&lt;0,001; ОШ 5,9; 95% ДИ 3,6–9,8). Треть пациентов в обеих группах имели хроническую головную боль напряжения (ГБН). Эпизодическая мигрень и эпизодическая ГБН превалировали у пациентов без ЛИГБ (р&lt;0,001). Пациенты в группе с ЛИГБ были чаще разведены (11,7 и 2,9% соответственно; р=0,002; ОШ 4,5; 95% ДИ 1,6–12,2). Большинство пациентов (76%) в обеих группах были работающими, имели высшее образование (65% с ЛИГБ и 74% без ЛИГБ) и состояли в браке (63% с ЛИГБ и 72% без ЛИГБ). При анализе более 20 коморбидных нозологий выявлено, что с развитием ЛИГБ наиболее часто ассоциировались три фактора: хроническая инсомния (60,2 и 47,4% соответственно; p=0,02; ОШ 1,7; 95% ДИ 1,1–2,6), синдром беспокойных ног (37,4 и 22% соответственно; p=0,002; ОШ 2,1; 95% ДИ 1,3–3,4) и субъективные когнитивные нарушения (76 и 53,2% соответственно; р&lt;0,001; ОШ 2,8; 95% ДИ 1,8–4,8).</p></sec><sec><title>Заключение</title><p>Заключение. Нарушения сна, субъективные когнитивные нарушения, семейное положение пациентов наиболее часто ассоциируются с ЛИГБ, что указывает на большое значение этих факторов в развитии ЛИГБ и открывает новые возможности ее профилактики.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>лекарственно-индуцированная головная боль</kwd><kwd>абузусная головная боль</kwd><kwd>факторы риска</kwd><kwd>коморбидная патология</kwd><kwd>демографические факторы</kwd><kwd>хроническая инсомния</kwd><kwd>когнитивный дефицит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>medication overuse headache</kwd><kwd>risk factors</kwd><kwd>comorbid pathology</kwd><kwd>demographic factors</kwd><kwd>chronic insomnia</kwd><kwd>cognitive deficit</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022 Apr 12;23(1):34. doi: 10.1186/s10194-022-01402-2</mixed-citation><mixed-citation xml:lang="en">Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022 Apr 12;23(1):34. doi: 10.1186/s10194-022-01402-2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Schwedt TJ, Buse DC, Argoff CE, et al. Medication Overuse and Headache Burden: Results From the CaMEO Study. Neurol Clin Pract. 2021 Jun;11(3):216-26. doi: 10.1212/CPJ.0000000000001037</mixed-citation><mixed-citation xml:lang="en">Schwedt TJ, Buse DC, Argoff CE, et al. Medication Overuse and Headache Burden: Results From the CaMEO Study. Neurol Clin Pract. 2021 Jun;11(3):216-26. doi: 10.1212/CPJ.0000000000001037</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Табеева ГР, Осипова ВВ, Филатова ЕГ и др. Диагностика и лечение лекарственно-индуцированной головной боли: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2022;14(1):4-13. doi: 10.14412/2074-2711-2022-1-4-13</mixed-citation><mixed-citation xml:lang="en">Tabeeva GR, Osipova VV, Filatova EG, et al. Evaluation and treatment of medication-overuse headache: Russian experts' guidelines. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(1):4-13. doi: 10.14412/2074-2711-2022-1-4-13 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers. 2023 Feb 2;9(1):5. doi: 10.1038/s41572-022-00415-0</mixed-citation><mixed-citation xml:lang="en">Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers. 2023 Feb 2;9(1):5. doi: 10.1038/s41572-022-00415-0</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Schwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication over-use in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-z</mixed-citation><mixed-citation xml:lang="en">Schwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication over-use in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wang YF, Tzeng YS, Yu CC, et al. Sex differences in the clinical manifestations related to dependence behaviors in medication-over-use headache. J Headache Pain. 2023 Nov 1;24(1):145. doi: 10.1186/s10194-023-01685-z</mixed-citation><mixed-citation xml:lang="en">Wang YF, Tzeng YS, Yu CC, et al. Sex differences in the clinical manifestations related to dependence behaviors in medication-over-use headache. J Headache Pain. 2023 Nov 1;24(1):145. doi: 10.1186/s10194-023-01685-z</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ljubisavljevic S, Ljubisavljevic M, Damjanovic R, Kalinic S. A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities. Brain Sci. 2023 Oct 1;13(10):1408. doi: 10.3390/brainsci13101408</mixed-citation><mixed-citation xml:lang="en">Ljubisavljevic S, Ljubisavljevic M, Damjanovic R, Kalinic S. A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities. Brain Sci. 2023 Oct 1;13(10):1408. doi: 10.3390/brainsci13101408</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Тверитин ЕА, Князева ЯА, Сизикова ЕА и др. Анализ жалоб на нарушения сна как индикатор низкого качества сна у больных с первичными головными болями. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски.2023;123(5-2):89-94. doi: 10.17116/jnevro202312305289</mixed-citation><mixed-citation xml:lang="en">Tveritin EA, Knyazeva YaA, Sizikova EA, et al. An analysis of complaints about sleep disorders as an indicator of poor sleep quality inpatients with primary headache disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5-2):89-94. doi: 10.17116/jnevro202312305289 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202</mixed-citation><mixed-citation xml:lang="en">Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Полуэктов МГ. Диагностика и лечение расстройств сна. В кн.: Полуэктов МГ, редактор. Краткий справочник на основе терминов 3-й версии Международной классификации расстройств сна 2014 г. Москва: МЕДпресс-информ; 2016. С. 1-45.</mixed-citation><mixed-citation xml:lang="en">Poluektov MG. Diagnosis and treatment of sleep disorders. In: Poluektov MG, editor. A short reference based on the terms of the 3rd version of the International Classification of Sleep Disorders 2014. Moscow: MEDpress-inform, 2016. Р. 1-45 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. doi: 10.1093/sleep/14.6.540</mixed-citation><mixed-citation xml:lang="en">Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. doi: 10.1093/sleep/14.6.540</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Морозова МА, Потанин СС, Бениашвили АГ и др. Валидация русскоязычной версии Госпитальной шкалы тревоги и депрессии в общей популяции. Профилактическая медицина. 2023;26(4):7-14. doi: 10.17116/profmed2023260417</mixed-citation><mixed-citation xml:lang="en">Morozova MA, Potanin SS, Beniashvili AG, et al. Validation of the Hospital Anxiety and Depression Scale Russian-language version in the general population. Profilakticheskaya meditsina = Russian Journal of Preventive Medicine. 2023;26(4):7-14. doi: 10.17116/profmed2023260417 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953-9. doi: 10.7326/0003-4819-121-12-199412150-00009</mixed-citation><mixed-citation xml:lang="en">Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953-9. doi: 10.7326/0003-4819-121-12-199412150-00009</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Путилина МВ. Астенические расстройства как проявление синдрома хронической усталости. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(8):125-30. doi: 10.17116/jnevro2021121081125</mixed-citation><mixed-citation xml:lang="en">Putilina MV. Asthenic disorders as a manifestation of chronic fatigue syndrome. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(8):125-30. doi: 10.17116/jnevro2021121081125 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lam RW, Lamy FX, Danchenko N, et al. Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-77. doi: 10.2147/NDT.S175188</mixed-citation><mixed-citation xml:lang="en">Lam RW, Lamy FX, Danchenko N, et al. Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-77. doi: 10.2147/NDT.S175188</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Strober LB, Binder A, Nikelshpur OM, et al. The Perceived Deficits Questionnaire: Perception, Deficit, or Distress? Int J MS Care. 2016 Jul-Aug;18(4):183-90. doi: 10.7224/1537-2073.2015-028</mixed-citation><mixed-citation xml:lang="en">Strober LB, Binder A, Nikelshpur OM, et al. The Perceived Deficits Questionnaire: Perception, Deficit, or Distress? Int J MS Care. 2016 Jul-Aug;18(4):183-90. doi: 10.7224/1537-2073.2015-028</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">WHO Guidelines on Physical Activity and Sedentary Behaviour. Geneva: World Health Organization; 2020.</mixed-citation><mixed-citation xml:lang="en">WHO Guidelines on Physical Activity and Sedentary Behaviour. Geneva: World Health Organization; 2020.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Implementation of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Epidemiol Bull. 1997 Mar;18(1):1-4.</mixed-citation><mixed-citation xml:lang="en">Implementation of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Epidemiol Bull. 1997 Mar;18(1):1-4.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sarchielli P, Corbelli I, Messina P, et al; SAMOHA Study Group. Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. Eur J Neurol. 2016 Jan;23(1):85-91. doi: 10.1111/ene.12794. Epub 2015 Jul 31.</mixed-citation><mixed-citation xml:lang="en">Sarchielli P, Corbelli I, Messina P, et al; SAMOHA Study Group. Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. Eur J Neurol. 2016 Jan;23(1):85-91. doi: 10.1111/ene.12794. Epub 2015 Jul 31.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Torres-Ferrus M, Ursitti F, Alpuente A, et al; School of Advanced Studies of European Headache Federation (EHF-SAS). From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain. 2020 Apr 29;21(1):42. doi: 10.1186/s10194-020-01111-8</mixed-citation><mixed-citation xml:lang="en">Torres-Ferrus M, Ursitti F, Alpuente A, et al; School of Advanced Studies of European Headache Federation (EHF-SAS). From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain. 2020 Apr 29;21(1):42. doi: 10.1186/s10194-020-01111-8</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J, Cho SJ, Kim WJ, et al. Impact of migraine on the clinical presentation of insomnia: a population-based study. J Headache Pain. 2018 Sep 14;19(1):86. doi: 10.1186/s10194-018-0916-5</mixed-citation><mixed-citation xml:lang="en">Kim J, Cho SJ, Kim WJ, et al. Impact of migraine on the clinical presentation of insomnia: a population-based study. J Headache Pain. 2018 Sep 14;19(1):86. doi: 10.1186/s10194-018-0916-5</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Suzuki K, Suzuki S, Haruyama Y, et al. Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine. Front Neurol. 2024 Feb 26;15:1373574. doi: 10.3389/fneur.2024.1373574</mixed-citation><mixed-citation xml:lang="en">Suzuki K, Suzuki S, Haruyama Y, et al. Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine. Front Neurol. 2024 Feb 26;15:1373574. doi: 10.3389/fneur.2024.1373574</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Buse DC, Rains JC, Pavlovic JM, et al. Sleep disorders among people with migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2019 Jan;59(1):32-45. doi: 10.1111/head.13435. Epub 2018 Nov 1.</mixed-citation><mixed-citation xml:lang="en">Buse DC, Rains JC, Pavlovic JM, et al. Sleep disorders among people with migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2019 Jan;59(1):32-45. doi: 10.1111/head.13435. Epub 2018 Nov 1.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
